A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion

Conditions: Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers Interventions: Drug: AMG 193; Drug: Gemcitabine; Drug: Nab-paclitaxel; Drug: Cisplatin; Drug: Pembrolizumab; Drug: Modified FOLFIRINOX Sponsors: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials